Integrated Selling And Marketing Expenses from 2010 to 2024

IDHC Stock   0.44  0.01  2.22%   
Integrated Diagnostics Selling And Marketing Expenses yearly trend continues to be comparatively stable with very little volatility. Selling And Marketing Expenses will likely drop to about 92 M in 2024. From the period from 2010 to 2024, Integrated Diagnostics Selling And Marketing Expenses quarterly data regression had r-value of  0.91 and coefficient of variation of  59.71. View All Fundamentals
 
Selling And Marketing Expenses  
First Reported
2013-01-31
Previous Quarter
55.2 M
Current Value
86.9 M
Quarterly Volatility
23.8 M
 
Yuan Drop
 
Covid
Check Integrated Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integrated Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 421.3 M, Selling General Administrative of 168.1 M or Selling And Marketing Expenses of 92 M, as well as many indicators such as . Integrated financial statements analysis is a perfect complement when working with Integrated Diagnostics Valuation or Volatility modules.
  
This module can also supplement various Integrated Diagnostics Technical models . Check out the analysis of Integrated Diagnostics Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Integrated Stock Analysis

When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.